BioSpace News Archive

Chad T. Lefteris, an executive with deep experience in integrated and academic health systems, was named chief operating officer for UCI Health, the patient-care organization of the University of California, Irvine

As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics is proud to announce that it has launched a new set of antibodies specific to cytotoxic drugs for life science community facing the growing challenges for scientific research.

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced an update of the ProSTAR study, its ongoing Phase 1b/2 clinical trial of CPI-1205 in patients with metastatic castration-resistant prostate cancer (mCRPC).

The NCSBN Board of Directors (BOD) voted on Dec. 4, 2018, to uphold the current passing standard for the NCLEX-RN Examination.

The Patented Medicine Prices Review Board (PMPRB), through the National Prescription Drug Utilization Information System (NPDUIS) research initiative, today published the latest edition of the Market Intelligence Report: Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Drugs for Retinal Conditions, 2017.

ACMG heads to a new destination this year in Seattle, Washington.

Samsung Electronics America, Inc. and Boys & Girls Clubs of America joined forces again for the 4th annual Climate Superstars Challenge.

The opioid crisis continues to devastate communities and families from coast to coast to coast. Collecting and sharing data helps inform policies and interventions that will have a direct impact on the people most affected by this crisis.

Ophthotech Corporation (NASDAQ:OPHT) announced today the election of Adrienne L. Graves, Ph.D., former Chief Executive Officer of Santen Inc., the U.S. arm of Japan’s largest ophthalmic pharmaceutical company, to its Board of Directors, effective immediately.

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced that Aron Knickerbocker, Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference, Wednesday, January 9, 2019 at 2:00 pm PT.